Investment analysts at Lifesci Capital issued their Q1 2025 EPS estimates for Protara Therapeutics in a note issued to ...
Fintel reports that on March 14, 2025, Cantor Fitzgerald initiated coverage of Protara Therapeutics (NasdaqGM:TARA) with a ...
Cantor Fitzgerald initiated coverage of Protara Therapeutics (TARA) with an Overweight rating and no price target The firm sees “multi-bagger ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
President Trump sent markets into another tailspin by announcing additional tariffs on Canada, suggesting a falling stock ...
Rolinda Acres presents a remarkable narrative of blending tradition with technology, guided by both heritage and adaptability ...